Dynamics and control of percutaneous drug absorption in the presence of epidermal turnover

Journal of Pharmaceutical Sciences

Volumn 98, Issue 1, 2009, Pages 187-204

  Simon, Laurent ^a   Goyal, Amit ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Desquamation; Diffusion; Drug administration protocol; Drug transport; Epidermal turnover; Mathematical model; Percutaneous; Process control theory; Simulations; Transdermal drug delivery

Indexed keywords

ADVECTION; ARTICLE; DESQUAMATION; DIFFUSION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; EPIDERMIS; MATHEMATICAL MODEL; SKIN; SKIN ABSORPTION;

EID: 58149233998     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21408     Document Type: Article

References (31)

1. Stanos SP. 2007. Topical agents for the management of musculoskeletal pain. J Pain Symptom Manage 33:342-355.
2. Lee AJ, King RJ, Rogers TG. 1996. A multiple-pathway model for the diffusion of drugs in skin. J Math Appl Med Biol 13:127-150.
3. Bando H, Sahashi M, Takagi T, Yamashita F, Takakura Y, Hashida M. 1996. Analysis of in vitro skin penetration of acyclovir prodrugs based on a diffusion model with a metabolic process. Int J Pharm 135:91-102.
4. Bando H, Mohri S, Yamashita F, Takakura Y, Hashida M. 1997. Effects of skin metabolism on percutaneous penetration of lipophilic drugs. J Pharmaceut Sci 86:759-761.
5. Fernandes M, Simon L, Loney NW. 2005. Mathematical modeling of transdermal drug-delivery systems: Analysis and applications. J Membr Sci 256:184-192.
6. Bunge AL. 1998. Release rates from topical formulations containing drugs in suspension. J Control Release 52:141-148.
7. Kalia YN, Guy RH. 2001. Modeling transdermal drug release. Adv Drug Del Rev 48:159-172.
8. Reddy MB, Guy RH, Bunge AL. 2000. Does epidermial turnover reduce percutaneous penetration? Pharm Res 17:1414-1419.
9. Milstone LM. 2004. Epidermal desquamation. J Dermatol Sci 36:131-140.
10. Roberts MS, Cross SE, Anissimov YG. 2002. Factors affecting the formation of a skin reservoir for topically applied solutes. Skin Pharmacol Physiol 17: 3-16.
11. Schmid D, Belser E, Liechti C, Zuelli F. 2006. Skin rejuvenation with a biomimetic peptide designed to promote desquamation. SÖFW-Journal 132: 2-6.
12. Long SA, Wertz PW, Strauss JS, Downing DT. 1985. Human stratum corneum polar lipids and desquamation. Arch Dermatol Res 277:284-287.
13. Seok YH, Hyun BS, Hwan OC. 2002. Quantitative measurement of desquamation and skin elasticity in diabetic patients. Skin Res Technol 8:250-254.
14. See A, Wright S, Denham JW. 1998. A pilot study of dermofilm in acute radiation-induced desquamative skin reactions. Clin Oncol (R Coll Radiol) 10:182-185.
15. Zhang CF, Yang ZL, Zhang CF, Luo JB. 2006. Effects of enantiomer and isomer permeation enhancers on transdermal delivery of ligustrazine hydrochloride. Pharm Dev Technol 11:417-424.
16. Higuchi T. 1963. Mechanisms of sustained action medication: theoretical analysis of the rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145-1149.
17. Crank J. 1975. The mathematics of diffusion. 2nd edition. Oxford, England: Oxford University Press, pp. 11-103.
18. Guy RH, Hadgraft J. 1992. Rate control in transdermal delivery? Int J Pharm 82:R1-R6.
19. Goyal A, Mandapuram S, Michniak B, Simon L. 2007. Application of orthogonal collocation and regression techniques for recovering parameters of a two-pathway transdermal drug-delivery model. Comput Chem Eng 31:107-120.
20. Pedreira CE, Vila VB. 1991. Optimal schedule for cancer chemotherapy. Math Program 52:11-17.
21. Simon L. 2007. Analysis of heat-aided membrane-controlled drug release from a process control perspective. Int J Heat Mass Transfer 50:2425-2433.
22. Lu X, Ramirez F, Anseth K. 1998. Modeling and optimization of drug release from laminated polymer matrix devices. AIChE J 44:1689-1696.
23. Blatt M, Schittkowski K. 2000. Optimal control of one-dimensional partial differential algebraic equations with applications. Ann Oper Res 98:45-64.
24. Auton TR, Westhead DR, Woolen BH, Scott RC, Wilks MF. 1994. A physiologically based mathematical model of dermal absorption in man. Hum Exp Toxicol 13:51-60.
25. Anissimov YG, Roberts MS. 2004. Diffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics. J Pharm Sci 93:470-487.
26. Damm DL, Fedorov AG. 2006. Reduced-order transient thermal modeling for SOFC heating and cooling. J Power Sources 159:956-967.
27. Maurya MR, Katare SR, Patkar PR, Rundell AE, Venkatasubramanian V. 2006. A systematic framework for the design of reduced-order models for signal transduction pathways from a control theoretic perspective. Comput Chem Eng 30:437-452.
28. Seborg DE, Edgar TF, Mellichamp DA. 1989. Process dynamics and control (Wiley Series in Chemical Engineering). New York City: John Wiley & Sons. pp. 339-353.
29. Ogunnaike BA, Ray WH. 1994. Process dynamics, modeling, and control (Topics in Chemical Engineering). USA: Oxford University Press, pp. 139-167.
30. Bryson AE. 1999. Dynamic optimization. Menlo Park: Addison Wesley Longman Inc. pp. 45-197.
31. Abate J, Valkó PP. 2004. Multi-precision laplace transform inversion. Int J Numer Meth Eng 60: 979-993.